Virtual Medicinal Product (VMP) - Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral suspension

Navigation

Name Details

Name Start Date End Date
Name Current Name Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral suspension Start Date 25-03-2010 End Date
Previous Name Previous Name Magnesium glycerophosphate 97.2mg/5ml (magnesium 4mmol/5ml) oral suspension Start Date 04-09-2006 End Date 24-03-2010
Abbreviated Name Abbreviated Name Magn glycerophos (mag 97.2mg/5ml (4mmol/5ml)) susp Start Date 25-03-2010
Previous Abbreviated Name Magnesium glycerophos 97.2mg/5ml (magnesium 4mmol/5ml) susp Previous Start Date 01-05-2009 Previous End Date 24-03-2010

Unit Dose & Form Information

DF Indicator
Continuous

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral suspension
Ontology Form/Route
suspension.oral
Name Basis
Other

Codes

ATC Code
A12CC
BNF Codes
  • BNF code 09050103
SNOMED Codes
Code Start Date End Date
8661511000001100 22-11-2004

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Magnesium glycerophosphate Based on Base Substance Magnesium 19.44 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 ml
100 ml